We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+10.14%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$34.9B
AUM Growth
+$1.28B
Cap. Flow
-$1.64B
Cap. Flow %
-4.71%
Top 10 Hldgs %
9.34%
Holding
1,542
New
95
Increased
448
Reduced
551
Closed
107

Top Buys

Rank Stock Value
1
GCO icon
Genesco
GCO
+$91.8M
2
SCSC icon
Scansource
SCSC
+$41.1M
3
VMI icon
Valmont Industries
VMI
+$41M
4
LF
LEAPFROG ENTERPRISES INC.
LF
+$40.5M
5
SYNA icon
Synaptics
SYNA
+$37.8M

Sector Composition

Rank Sector Weight
1 Industrials 24.69%
2 Technology 17.96%
3 Consumer Discretionary 14.71%
4 Financials 10.17%
5 Materials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THO icon
1
Thor Industries
THO
$3.97B
$416M 1.19%
7,526,122
-179,995
-2% -$9.94M
RS icon
2
Reliance Steel & Aluminium
RS
$20B
$405M 1.16%
5,341,972
-67,900
-1% -$5.02M
BKE icon
3
Buckle
BKE
$2.21B
$403M 1.15%
7,844,605
+51,960
+0.7% +$2.57M
UNT
4
DELISTED
UNIT Corporation
UNT
$357M 1.02%
6,911,360
-305,526
-4% -$15.2M
FHI icon
5
Federated Hermes
FHI
$4.84B
$355M 1.02%
12,340,344
-186,734
-1% -$5.12M
NUS icon
6
Nu Skin
NUS
$233M
$302M 0.87%
2,187,208
-1,829,697
-46% -$215M
LECO icon
7
Lincoln Electric
LECO
$15.8B
$278M 0.8%
3,891,986
-1,279,255
-25% -$89.8M
MTX icon
8
Minerals Technologies
MTX
$2.25B
$249M 0.71%
4,140,589
-187,730
-4% -$10.6M
TER icon
9
Teradyne
TER
$58.2B
$247M 0.71%
14,029,064
-1,329,089
-9% -$22.5M
WLK icon
10
Westlake Corp
WLK
$9.45B
$247M 0.71%
4,046,436
-434,400
-10% -$24.4M
HP icon
11
Helmerich & Payne
HP
$4.24B
$246M 0.7%
2,922,800
-84,610
-3% -$6.59M
UNF icon
12
Unifirst Corp
UNF
$5.17B
$243M 0.7%
2,273,700
+100,912
+5% +$10.3M
MATV icon
13
Mativ Holdings
MATV
$672M
$241M 0.69%
4,679,305
+524,208
+13% +$29M
MKSI icon
14
MKS Inc
MKSI
$18.3B
$239M 0.69%
7,984,200
+487,471
+7% +$14.2M
VMI icon
15
Valmont Industries
VMI
$9.28B
$233M 0.67%
1,561,635
+289,980
+23% +$41M
Y
16
DELISTED
Alleghany Corp
Y
$233M 0.67%
581,513
-5,405
-0.9% -$2.16M
MYGN icon
17
Myriad Genetics
MYGN
$304M
$227M 0.65%
10,843,075
-163,500
-1% -$4.14M
ENS icon
18
EnerSys
ENS
$6.89B
$227M 0.65%
3,237,472
-236,026
-7% -$15.8M
TW
19
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$223M 0.64%
1,749,613
-828,890
-32% -$96.4M
KMT icon
20
Kennametal
KMT
$2.3B
$223M 0.64%
4,278,038
+94,967
+2% +$4.5M
POLY
21
DELISTED
Plantronics, Inc.
POLY
$212M 0.61%
4,556,160
-128,426
-3% -$5.79M
WWD icon
22
Woodward
WWD
$20.4B
$212M 0.61%
4,638,524
CGNX icon
23
Cognex
CGNX
$10.6B
$206M 0.59%
10,787,208
-2,612,200
-19% -$42.4M
RBA icon
24
RB Global
RBA
$15.9B
$200M 0.57%
8,704,454
+470,684
+6% +$9.63M
AVX
25
DELISTED
AVX Corporation
AVX
$199M 0.57%
14,254,683
+478,724
+3% +$6.49M

Similar funds

Royce & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Royce & Associates held 1,542 positions worth $34.9B, up 3.8% from $33.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Royce & Associates withdrew a net $1.64B in Q4 2013, closing 107 positions and reducing 551 holdings. Its most notable exit was JOS A BANK CLOTHIERS INC, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Scansource worth $44.2M.

  • Royce & Associates's largest Q4 2013 buy was Scansource: 1,041,300 shares worth $44.2M.
  • Royce & Associates added most to Genesco in Q4 2013, an estimated $91.8M increase.
  • Royce & Associates's biggest Q4 2013 reduction was Nu Skin, cutting an estimated $215M.
  • Royce & Associates fully exited JOS A BANK CLOTHIERS INC in Q4 2013, selling an estimated $121M.
  • Royce & Associates's ten largest holdings make up 9.3% of its $34.9B portfolio in Q4 2013.
  • Royce & Associates opened 95 new positions and closed 107 in Q4 2013.
  • Royce & Associates's portfolio value rose 3.8% quarter-over-quarter to $34.9B.

Based on Royce & Associates's 13F filing for Q4 2013, filed 10 Feb 2014.